<DOC>
	<DOCNO>NCT01832311</DOCNO>
	<brief_summary>The purpose study compare level several immunoregulatory factor serums aqueous humor type II diabetes cataract patient senile non-diabetic cataract patient since disturbed cytokine growth factor microenvironment diabetic eye may contribute increased frequency intraoperative postoperative intraocular lens surgery complication .</brief_summary>
	<brief_title>Protein Profile Immunoregulatory Factors Diabetic Cataract</brief_title>
	<detailed_description>The study compare level several immunoregulatory molecule ( vascular endothelial growth factor ( VEGF ) , monocyte chemotactic protein-1 ( MCP-1 ) , Fas Ligand ( FasL ) , interleukin-10 ( IL-10 ) interleukin-17 ( IL-17 ) ) serum aqueous humor type 2 diabetes mellitus patient , without clinically evident diabetic retinopathy diabetic macular edema , nondiabetic cataract patient . Investigators also investigate whether concentration immunoregulatory molecule significantly correlate intraoperative postoperative parameter . Particularly , investigator focus development corneal edema one main cause low visual acuity immediate postoperative period intraocular lens implantation . Since disturbed cytokine growth factor microenvironment diabetic eye may contribute increased frequency intraoperative postoperative intraocular lens ( IOL ) surgery complication , finding may relevant development therapeutic strategy aim restore protein profile immunoregulatory factor parallel cataract treatment .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>patient undergo phacoemulsification combine IOL implantation diabetic group : duration type 2 diabetes mellitus ( T2DM ) 10 15 year diabetic group : therapy oral hypoglycemic agent glycemic control ocular ( retinal ) systemic diabetic complication T2DM patient cataract could result ocular condition , systemic disease ( except T2DM diabetic group ) trauma patient immune disease , local systemic inflammation could affect cytokine concentration serum aqueous humor ( AH )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>cataract</keyword>
	<keyword>cytokine</keyword>
	<keyword>chemokines</keyword>
	<keyword>aqueous humor</keyword>
</DOC>